Protara Therapeutics Inc. (TARA)
3.44
-0.30 (-8.02%)
At close: Mar 03, 2025, 3:59 PM
3.23
-6.24%
After-hours: Mar 03, 2025, 07:17 PM EST
Protara Therapeutics Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Cash & Equivalents | 39.59M | 24.13M | 35.72M | 168.6M | 6.18M | 19.37M | 21.17M | 36.39M | 40.03M | 68.84M | 2.83M | 2.41M |
| Short-Term Investments | 25.99M | 60.24M | 55.51M | n/a | n/a | 2.5M | 20.97M | 4.92M | 25.23M | 14.76M | 2.36M | 5.1M |
| Long-Term Investments | n/a | 17.89M | 39.47M | 745K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 3.69M | 1.39M | 1.61M | 2.96M | 122K | 22K | 240K | 393K | 706K | 114K | -1 | -1 |
| Receivables | 242K | 486K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Inventory | n/a | 1.16M | 1.22M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 2.88M | 1.29M | 1.88M | 837K | 200K | 1.37M | 22.31M | 6.36M | 26.58M | 15.76M | 139K | 193K |
| Total Current Assets | 68.7M | 86.15M | 93.11M | 169.44M | 6.97M | 23.24M | 43.48M | 42.76M | 66.61M | 84.6M | 5.33M | 7.7M |
| Property-Plant & Equipment | 6.56M | 7.87M | 8.89M | 1.24M | 459K | 263K | 259K | 372K | 224K | 83K | 62K | 79K |
| Goodwill & Intangibles | n/a | n/a | 29.52M | 29.52M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 10.25M | 27.14M | 79.48M | 33.72M | 581K | 285K | 499K | 765K | 930K | 197K | 329K | 79K |
| Total Assets | 78.95M | 113.29M | 172.6M | 203.16M | 6.97M | 23.52M | 43.98M | 43.52M | 67.54M | 84.8M | 5.66M | 7.78M |
| Account Payables | 2.43M | 1.59M | 954K | 914K | 716K | 441K | 8.06K | n/a | n/a | n/a | 399K | 469K |
| Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | -28.06K | n/a | n/a | n/a | 2.95M | n/a |
| Short-Term Debt | 983K | 1.83M | 1.71M | 176K | n/a | n/a | 20K | n/a | n/a | n/a | 5.06M | n/a |
| Other Current Liabilities | 2.73M | 2.32M | 1.59M | 1.67M | 2.63M | 2.64M | 9.21M | 5.08M | 4.13M | 2.34M | 1.1M | 735K |
| Total Current Liabilities | 6.15M | 5.74M | 4.3M | 2.92M | 583K | 3.08M | 9.24M | 5.08M | 4.13M | 2.34M | 9.77M | 1.2M |
| Long-Term Debt | 4.48M | 5.47M | 6.38M | 999K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Liabilities | 4.48M | 5.47M | 6.38M | 999K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.95M |
| Total Liabilities | 10.63M | 11.21M | 10.68M | 3.91M | 583K | 3.08M | 9.24M | 5.08M | 4.13M | 2.34M | 9.77M | 4.15M |
| Total Debt | 5.47M | 6.38M | 7.24M | 1.09M | n/a | n/a | 20K | n/a | n/a | n/a | 5.06M | n/a |
| Common Stock | 11K | 11K | 11K | 11K | 3K | 19K | 18K | 17K | 16K | 16K | n/a | n/a |
| Retained Earnings | -200.38M | -159.96M | -94.01M | -46.76M | -225.46M | -210.47M | -189.74M | -159.78M | -131.25M | -109.87M | -100.51M | -86.66M |
| Comprehensive Income | -31K | -688K | -211K | 0.00 | 3K | 5K | -14K | -565K | -11K | -12K | n/a | 1K |
| Shareholders Equity | 68.32M | 102.08M | 161.91M | 199.24M | 6.39M | 20.44M | 34.74M | 38.44M | 63.41M | 82.46M | -4.11M | 3.63M |
| Total Investments | 25.99M | 78.13M | 94.97M | 745K | n/a | 2.5M | 20.97M | 4.92M | 25.23M | 14.76M | 2.36M | 5.1M |